跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROSUVASTATINA SWANPOND INVESTMENTS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ROSUVASTATINA SWANPOND INVESTMENTS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
ROSUVASTATINA SWANPOND INVESTMENTS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Swan Pond Investments Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 14, 2020
Approval ID
c79287b3eb4405ab
Company
Swan Pond Investments Limited
Type
Standard
Approval Details
Approval Id
c79287b3eb4405ab
Drug Cima Aemps Name
ROSUVASTATINA SWANPOND INVESTMENTS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85348
Holder Company Name
Swan Pond Investments Limited
Marketing Company Name
Swan Pond Investments Limited
Authorization Date
2020-08-14
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
No
Company Name
Swan Pond Investments Limited
Active Ingredients
ROSUVASTATINA CALCICA
5,20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 14, 2020
Approval ID
c79287b3eb4405ab
Type
Standard
Back to CIMA-AEMPS Approvals